| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
BEDFORD, Mass.—As an in vitro measure of the absorption of compounds by human cells, PAMPA has found increasing use in recent years. While the assay works well for most compounds, however, it often inaccurately characterizes some high-permeability compounds as poor absorbers. At the recent SBS conference in Seattle, researchers at BD Biosciences described a new PAMPA membrane formulation that dramatically reduces the error rate.
 
Using standard 96-well PVDF filter plates, the researchers used a proprietary coating method (about which they offered no information) to layer a DOPC artificial membrane. They then compared the permeability of a variety of well and poorly absorbed compounds through the new and traditional PAMPA plates with literature data for in vivo human absorption.
 
The researchers found that the new DOPC coating method provided superior results for compounds that tended to give false-negative results in traditional PAMPA, with permeabilities much closer to literature values. Furthermore, they found the new PAMPA plates offered lower mass retention of "sticky" compounds.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue